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Macrophage Stimulation and the
Inflammatory Response to Asbestos
by J. A. Hamilton*
Chrysotile fibers injected into the peritoneal cavity of mice elicit a cellular exudate. Macrophages
appearing in this exudate produce high levels of the neutral protease, plasminogen activator, when
cmpared with the resident peritoneal macrophage population. In contrast, the levelsoflysozyme and two
lysosomal enzymes are the same for the two macrophage types. The asbestos-induced macrophages
producing the plasminogen activator appear to have descended from recently divided precursors. Low
concentrations ofanti-inflammatory glucocorticoids inhibit macrophage plasminogen activatorsynthesis.
Preliminaryexperimentsindicatethatdifferentasbestostypesinducehyperemiainskin,andalsoshorten
the partial thromboplastin time of plasma and generate the release of kinins.
Ihese observations could be interrelated and are suggested as representing some aspects ofthe inflam-
matory response of the host to asbestos exposure.
Introduction
Asbestos exposure appears to be associated with
the development of a chronic granulomatous re-
sponse (1) which leads to fibrosis surrounding the
respiratory bronchioles and alveoli. It is apparent
that additional biological assays are needed to
analyze thebiological events giving rise toasbestosis
and, in some cases, neoplasms, and also to deter-
mine what structural features ofasbestos fibers con-
tribute to the development of these pathological
changes. In this paper I present data on various
aspects of the inflammatory response to asbestos
fibers, viz., macrophage stimulation, quantitation of
certain vascular changes, and interaction with
plasma components. Apart from the obvious impli-
cations for the elucidation ofthe mechanisms oftis-
sue damage and fibrosis, it could be relevant to
asbestos-induced carcinogenesis as itispossible that
the inflammatory response to asbestos is contrib-
uting to the progression of tumors.
Macrophages, a cell type present both in normal
alveoli and in chronic inflammatory reactions, are
often conspicuous in asbestos-induced lesions (2).
When macrophages are stimulated in vivo orin vitro,
they can secrete a number ofbiologically important
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molecules. These include interferon (3), proteolytic
enzymes (24), complement components (5), pros-
taglandins (6), colony-stimulating activity (7), and
fibrogenic factors (8). It is likely that the initial event
after inhalation oftoxic particles such as asbestos is
their attachment to and often phagocytosis by
mononuclear phagocytes in the alveoli (9). Several
workers have added different types of asbestos in
vitro to both organ cultures and macrophages from
several different species (10-16). In spite ofthe mul-
titudinous conditions employed, it is possible to ar-
rive at some general conclusions. When serpentine
fibers (chrysotile A or B) are added to macrophages
in the absence of serum, marked early cytotoxicity
results. When macrophages are cultured in the pres-
ence of serum, exposure to asbestos fibers leads to
delayed cytotoxicity, manifested after one or more
days. Using lower concentrations of UICC
chrysotile A(1-50 ,tg/ml), Davies et al. (17) showed
that mouse peritoneal macrophages released
lysosomal enzymes; this release occurred in the ab-
sence ofany detectable cell death. We have studied
another enzyme system found in mouse peritoneal
macrophages, viz., plasminogen activator (18).
Peritoneal macrophages obtained from mice that
have received inflammatory stimuli such as thiogly-
collate, endotoxin, mineral oil, etc., produce plas-
minogen activator (4, 19) whereas the resident
peritoneal macrophages produce barely detectable
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production of this enzyme and an inflammatory re-
sponse in the peritoneal cavity. We therefore de-
cided to examine the in vivo and in vitro influence of
asbestos fibers on the plasminogen activator levels
ofmouse macrophages. We have been able to dem-
onstrate that UICC chrysotile Type B elicits macro-
phages into the peritoneal cavity ofmice which pro-
duce high levels ofthis protease; in vitro addition of
these same fibers to mouse peritoneal macrophages
stimulates enzyme production. Preliminary ex-
periments indicate that asbestos fibers increase the
bloodflow intointradermal sites ofinjectionand also
shorten the partial thromboplastin time of normal
human plasma.
Materials and Methods
Reagents
Reagents were obtained as follows: fetal bovine
serum (FBS) (Rehatuin FS, Reheis Chemical Com-
pany, Division of Armour Pharmaceutical Co.,
Phoenix, Arizona); asbestos, UICC ChrysotileType
B, a gift from Johns-Manville Corp.; Brewer thio-
glycollate medium (Difco Laboratories, Detroit,
Michigan); soybean trypsin inhibitor, component
VI, and bovine fibrinogen, fraction I (Miles Labora-
tories, Inc., Kankakee, Illinois); lactalbumin hy-
drolysate (Nutritional Biochemicals Corp., Cleve-
land, Ohio); outdated human plasma (New York
Blood Center, New York, New York); polystyrene
latex particles, 1.01 um (Dow Diagnostics, India-
napolis, Indiana); dexamethasone (Sigma Chemical
Co., St. Louis, Missouri); 125I-sodium iodide, car-
rier-free (Schwarz/Mann Division, Becton, Dickin-
son & Co., Orangeburg, New York). The dexameth-
asone was dissolved in ethanol prior to dilution in
phosphate buffered saline (PBS). Controls for the
effect ofthe ethanol were never different from those
of nontreated cultures. Endotoxin, S. minnesota
lipopolysaccharide mR595 (S418), was a gift from
Dr. 0. Luderitz, Max Planck Institut fur Immuno-
biologie, Freiburg, West Germany.
Peritoneal Exudates
Peritoneal cells were obtained from NCS (Rocke-
feller) mice (25-30 g) or BDF* mice, 8-12 weeks old
(Cumberland Farms) as previously described (4).
The mice were injected intraperitoneally with 1 ml
quantitiesofvarious irritants andthecellscollected4
days later. The cell yields after 4 days from asbes-
tos-primed animals were 6-12 x 106 cells, increasing
with the dose up to 100 ,ug, of which 30-40% were
macrophages, 30-40% polymorphonuclear leuko-
cytes (PMN) and 10-20% lymphocytes atthis dose of
asbestos. Thioglycollate-stimulated mice yielded
15-20 x 106 cells, consisting of80-90Wo macrophages
and 10-20% lymphocytes, while control mice gave
3-5 x 106 cells, ofwhich 30-40% were macrophages
and the remainder lymphocytes.
In Vivo Labeling of Asbestos-Induced
Macrophages with Tritiated
Thymidine (3H-TdR)
Four mice were given 10 ,uCi 3H-TdR (specific
activity 10 Ci/mmole) intramuscularly 6 and 1 hr
prior to an intraperitoneal injection ofasbestos (300
,g), thioglycollate medium (1 ml), or normal saline.
The 3H-TdRinjections were continued every 8 hrfor
the next 4 days. The peritoneal cells were harvested
4days afterthe initial injections ofthe irritants inthe
usual manner (4).
Autoradiography
For the analysis of the in vivo radiolabeled peri-
toneal cells, the thioglycollate populations were
plated at2.5 x 105 cells in Dulbecco's medium (DB),
supplemented with 10% fetal bovine serum that had
been heat-inactivated at 56°C for 30 min (HIFBS), in
Lab-Tek Chamber Slides (No. 4808); the asbestos
and control (normal saline) cells were plated at 7.5 x
105 cells per chamber to ensure a comparable
numberofmacrophages inthecultures. After24hrat
37C, the cells were washed twice with PBS and DB
+ 0.05% lactalbumin hydrolysate (LH) was added.
The conditioned media (CM) were collected, the
cells washed twicewith PBS andfixedwithCarnoy's
solution. The slides were dipped in Kodak Nuclear
Track Emulsion (NTB2), dried, and stored at 4°C.
After21 days, autoradiographs were developed with
Kodak D19 Developer for 5 min and fixed with
Kodak Rapid Fixer. Afterdeveloping, the cells were
stained with Giemsa's stain. Since background
levels in preparations from nonlabeled animals
showed less than three grains per nucleus, all cells
with three or more silver grains over the nucleus
were considered as positive.
Fibrinolysis Measurements
The cells were plated on 1251-fibrin-coated wells
(Linbro DisposoTrays, FB 16-24TC)for24 hrin DB
+ 5% HIFBS (20). At this stage, soybean trypsin
inhibitor (STI) (100 ,ug/ml) was added to prevent
fibrinolysis. Fibrinolysis measurementwasbegunby
washingthe cellstwice with PBS and placingthem in
DB supplemented with 5% acid-treated HIFBS
(ATHIFBS). The HIFBS is acid-treated then neu-
tralized to remove protease inhibitors during assay
(20). Fibrinolysis was estimated by withdrawing
Environmental Health Perspectives 70aliquots of medium and assaying them for radioac-
tivity in a Packard Autogamma Scintillation Spec-
trometer. The plasminogen dependence of the
fibrinolytic activity can be shown by assaying in the
presence ofATHIFBS from which the plasminogen
has been removed (21).
Plasminogen Activator Measurement
Alternatively, plasminogen activator can be as-
sayed in the serum-free medium from the mac-
rophages. Peritoneal cells were plated in DB + 5%
HIFBS atthe samedensity asaboveontissueculture
dishes (Falcon # 3001). After 24 hr, the cells were
washed twice with PBS and incubated in serum-free
conditioned medium consisting of DB + 0.05% LH
(4). After 48 hr, the serum-free CM were collected.
Serum-free CM were kept frozen at -20°C until as-
sayed for enzymatic activity. The plasminogen ac-
tivator in serum-free CM was assayed as described
(4, 20). 125I-Fibrin-coated wells of Linbro Disposo
Trays were used, and the assay mixture contained 2
,ug human plasminogen [purified from outdated
human plasma according to Deutsch and Merz (22)],
and 10 ,l CM in 250 ,ul 0.1M Tris, pH 8.1. All expe-
riments included appropriate controls for all re-
agents and media. No plasminogen-independent
fibrinolysis could be detected when plasminogen
was not included in the assay mixture. One unit of
plasminogen activator is defined as the amount that
stimulates the release of 10% of the initial radio-
activity in 4 hr (4).
Protein
Protein was measured by the method of Lowry
et al. (23) with the use of bovine serum albumin
standard.
Results
Effects of Intraperitoneal Injection
of Asbestos
Peritoneal CeUPopulation. It haspreviously been
shown (18) that intraperitoneal injection of UICC
chrysotile into mice increased the number of cells
obtained by peritoneal washing and also affected the
relative proportions ofthe different cell types pres-
ent. Because of the relatively large proportion of
PMNs (30-40% with 100 ,ug asbestos) present in
these exudates, the cells were preincubated for24 hr
to allow for death ofthe PMNs (4) prior to the com-
mencement ofany experiment. Afterwashing ofthe
cells, at least 95% ofthe remaining cells were iden-
tified as macrophages. The asbestos-induced
macrophages were larger and more vacuolated than
those from PBS-injected mice.
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FIGURE 1. Plasminogen-dependent fibrinolytic activity from dif-
ferent numbers of peritoneal macrophages. For the in vivo
priming, 100 ,ug asbestos was injected. Peritoneal cells on
1251-fibrin-coated Linbro wells were cultured in DB+5%
HIFBS+ 100 ,ug/ml STI for 24 hr, washed, and incubated in
DB+5% ATHIFBS. Samples were aliquoted and counted for
released radioactivity. The cell numbers are total peritoneal
cell numbers plated.
Fibrinolytic Activity ofAsbestos-Induced Macro-
phages. As shown previously, peritoneal exudate
macrophages produce increasing levels of a plas-
minogen-dependent fibrinolytic activity as the in
vivo asbestos dose increased (1-300 ,g), and the
enzyme was continually released for at least a4-day
period (18). Figure 1 shows that increasing fibrino-
lytic activity can be detected from asbestos-induced
macrophages as the peritoneal cell number is in-
creased from 4 x 105 until confluent macrophage
cultures are obtained from approximately 2 x 106
peritoneal cells/well.
Peritoneal cell populations from thioglycollate-
and PBS-primed animals are included for compari-
son. Again, there is continued increasing activity
with time over the 48 hr assay period. Owing to the
lower percentage of macrophages in an asbestos-
induced exudate compared to a thioglycollate-
induced population, cell confluence in the tissue
culture wells occurred at approximately 2 x 106
peritoneal cells from asbestos-induced populations
and8 x 105forthethioglycollate-inducedexudate. It
has previously been demonstrated that almost all of
the fibrinolytic activity is plasminogen-dependent
(18). In Table 1, a comparison is made between as-
Table 1. Flbrinolytic activity ofinduced peritoneal macrophages.6
Radioactivity
Macrophages released at 24 hr, %
Unstimulated (PBS) 1.4
Asbestos, 500 ;Lg 52.9
Latex, 500,ug 3.0
Endotoxin, 30 ug 4.9
a2 x 106 peritoneal cells (4 day exudates) were plated for 24 hr
on 1251-fibrin. After washing in PBS, DB + 5% ATHIFBS was
added to the cells and the plasminogen-dependent fibrinolytic
activity monitored by counting released 1251.
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71bestos and other agents in their ability to induce
fibrinolytically active cells.
Asbestos is quite potent at eliciting "active" mac-
rophages, in contrast to another nondigestible parti-
cle, latex.
Enzyme Secretion by Asbestos-Induced Macro-
phages. We also reported (18) that asbestos-induced
macrophages secreted at least 20 times more plas-
minogen activator than resident peritoneal macro-
phages, whereas the amount of lysozyme secreted
by the two types of macrophages was the same.
Likewise, no difference was observed between
asbestos-stimulated and control macrophages in the
secretion of two lysosomal enzymes, N-acetyl-,8-D-
glucosaminidase and 8-galactosidase (18). Hence,
the increased secretion of plasminogen activator by
asbestos-induced cells is a relatively specific re-
sponse and is not part of a general increase in lytic
enzyme synthesis.
In vivo Labeling of Macrophages with Tritiated
Thymidine (3H-TdR). It was then decided to deter-
mine how many asbestos-induced macrophages had
come from precursors which had undergone DNA
synthesis during the 4 day incubation period. Mice
were injected bothjustpriortothe asbestos injection
and also repeatedly for the 4 day period after this.
Table 2 indicates thatapproximately70oofthe mac-
rophages afterplating had incorporated 3H-TdR into
the nucleus. This was approximately the same value
obtained for the thioglycollate-induced macro-
phages, whereas the percentage of labeled mac-
rophages for the saline-treated control animals was
approximately 11%.
The higher proportion of labeled cells in the
stimulated populations, combined with the much
higher levels of plasminogen activator (PA) pro-
duced by these populations, make it appear likely
that the cells actively secreting PA are in fact the
cells which have descended from precursors which
had recently undergone DNA synthesis. Itcouldalso
be demonstrated that both ultra-violet irradiation
and also methotrexate were able to inhibit the gener-
ation of stimulated macrophages (as judged by PA
synthesis) into the peritoneal cavity after in-
traperitoneal administration of thioglycollate (un-
published observations).
Table 2. In Vivo labeling of macrophages with
tritiated thymidine (3H-TdR).a
Macrophages Labeled cells, %
Unstimulated 11 ± 1
Thioglycollate 69 ± 6
Asbestos 72 ± 4
aForexperimental protocol see Materials and Methods. Values
are means of triplicate cultures with standard errors.
Table 3. Effect of dexamethasone on the secretion
of plasminogen activator by macrophages from
asbestos-primed mice.a
Secreted
plasminogen
Cell activator,
Macrophages protein/dish, units/mg cell
(6 x 106) ,g protein
Asbestos (100 ,ug) 350 960
Asbestos + 10-7M dexamethasone 320 24
a24 hr afterplating in DB + 5% HIFBS in 35 mmdishes(Falcon
3001), asbestos-stimulated macrophageswerewashed, andplaced
inDB + 0.05% LH in the presence orabsence ofdexamethasone.
CM were collected 48 hr later.
Effect ofDexamethasone on Macrophage Fibrin-
olytic Activity. Low concentrations of certain
glucocorticoids can inhibit the synthesis and the
secretion of plasminogen activator from thio-
glycollate-stimulatedmacrophages (20). InTable3, a
similar reduction in enzyme secretion is obtained if
asbestos-primed macrophages are administered
dexamethasone in vitro.
Other Aspects oftheInflammatory Response
to Asbestos Fibers
We have recently dissected and quantitated two
parameters of the inflammatory response in rabbit
skin to asbestos fibers, viz., increased hyperemia
and vascular permeability (24). Six asbestos fibers
including chrysotiles and amphiboles induce in-
creases in both of these parameters. We have also
been able to demonstrate that asbestos fibers can
shorten the partial thromboplastin time of normal
plasma and, depending on the charge ofthe sample,
can also activatefactorXII to generate kininactivity
(25). Since both fibrin deposition and kinin action
have often been suggested to play important parts in
inflammatory responses, I wouldlike topropose that
such studies may also be useful in delineating how
asbestos interacts with host tissue to generate a
chronic inflammatory lesion.
Discussion
There appears to be an association between the
injection of an inflammatory stimulus into the
peritoneal cavity ofmice and the appearance ofmac-
rophages intothecavity whichproduce higherlevels
of the neutral protease, plasminogen activator.
UICC chrysotile fibers are also able to elicit stimu-
lated cells into the peritoneal cavity and also to
stimulate peritoneal macrophagesin vitro toproduce
more plasminogen activator (18). There does not
seem to be a similar association between inflamma-
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FIGURE2. Someofthepossible effectsresultingfromplasminogen
activator release from macrophages.
tory stimuli and the levels ofboth lysozyme and also
of enzymes of acid pH optima (18). Plasminogen
activatorand plasmin, the productformed after acti-
vation ofthe zymogen plasminogen, are both serine
proteases which function optimally around neutral
pH and hence at the pH of the extracellular milieu.
Plasmin is likely to be important in inflammatory
processes as it has been shown to activate certain
enzyme cascades such as the complement (26), the
clotting (27), and the kinin systems (28); in addition,
plasmin is most likely to be involved in tissue de-
struction as it has been shown to degrade basement
membrane and cartilage and also to activate a latent
collagenase (29-31). Some of these possible plas-
min-mediated events are depicted in Figure 2.
It is proposed that a part of the granulomatous
response to asbestos fibers might be the interaction
of asbestos with monocytes-macrophages resulting
in the plasmin-mediated destruction of neighboring
tissue and in the liberation of inflammatory medi-
ators. In supportoftheproposalthatthemacrophage
plasminogen activator-plasmin system might be
relevant for the processes of chronic inflammation
(particularly those associated with asbestosis), we
have been able to demonstrate that low concentra-
tions of anti-inflammatory steroids can inhibit mac-
rophage plasminogen activatorproduction. No such
influence was found on lysozyme synthesis nor on
lysosomal enzyme levels (18).
I propose that the mouse peritoneal macrophage
system is a convenient model system to understand
asbestos-macrophage interactions. However, it
would also seem important to test the interaction
with macrophage cell types that are of more direct
interest and are most likely to be in contact with
asbestos, viz., lung macrophages. Perhaps alveolar
macrophages from workers exposed to asbestos fi-
bers would produce more plasminogen activator
than the non-exposed counterparts. Since a single
cell assay is available for plasminogen activator de-
tection(20), itmightbe possible toanalyze suchcells
atthe singlecelllevel. Peritoneal macrophages might
also have a role in asbestos-associated neoplasms
because of the occurrence of peritoneal mesothe-
liomas.
As described previously (18), asbestos fibers can
stimulate mouse macrophages in vitro to produce
more plasminogen activator when added to the cells
in culture. The mechanisms of interaction of asbes-
tos fibers with macrophages are unknown, although
phagocytosis is possibly important. This question
can only be resolved ifmore defined fibers are used
and ifcells exposed to asbestosin vitro are examined
forintracellularfibersby suchtechniquesaselectron
microscopy. One observation which could be rele-
vant for agents such as asbestos is that persistent
phagocytic stimuli seem to be able to cause mac-
rophages to produce plasminogen activator continu-
ally as opposed to digestible materials (19). This
could have serious consequences, as there would be
no obvious way of reducing plasminogen activator
synthesis, particularly as the nondegradable asbes-
tos could be released from dying cells and taken up
by another cell. It would be worth exploring the
possibility ofmodifying asbestos fibers so that they
cannot cause macrophages to produce more plas-
minogen activator.
While I do notwishto imply that stimulationofthe
macrophage plasminogen activator-plasmin system
is the only critical event involved in the establish-
ment of the chronic lesions of asbestos, it could
represent an important feature. The structural
properties and the inflammatory host interactions
thatenable asbestosfibers toelicitmacrophagesinto
the peritoneal cavity are unknown at the present.
Some preliminary experiments designed to examine
such questions were mentioned above and are now
discussed.
The early vascular changes induced by asbestos
interaction with tissues have virtually been unex-
amined, although Pelfrene (32) recently elicited vas-
cular modifications in the hamster cheek pouch. We
have quantitated both the increased hyperemia and
vascular permeability elicited in rabbit skin to a
series of asbestos and related fibers. It is now be-
comingclearwithotherirritants thatincreased initial
blood flow in response to irritation (and damage) can
be a controlling influence on other vascular changes
(33). As hyperemia, vascular permeability and
leucocyte extravasation can now be measured in
various organs ofseveral species, it is suggested that
February 1980 73it might be appropriate to monitor these parameters
at tissue sites with asbestos involvement.
Thefactthatasbestosfiberscan shortenthe partial
thromboplastin time (PTT) and, depending on the
charge, can also generate kinin activity from normal
human plasma, may be partial explanations, at least,
for the relationship between asbestos inhalation,
lung disease and possibly neoplasia. This is because
both chronic activation of the coagulation system
leading to the deposition offibrin and the generation
of vascular mediators, and also the production of
kinins, are strongly implicated in the establishment
of chronic inflammatory lesions and eventually to
tissue destruction (34, 35).
In conclusion, I would like to suggest that I have
presented datarelevant to some oftheearly vascular
events associated with asbestos exposure and also
relevant to the role of inflammatory macrophages
responding to the asbestos stimulus.
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